Detail of the clinical trial

Title of the trial GvHD prophylaxis with ATG-Fresenius S in allogeneic stem cell transplantation from matched unrelated donors: a randomised phase III multi-center trial comparing a standard GvHD prophylaxis with cyclosporine A and methotrexate with additional transplant ATG-Fresenius S
EudraCT number 2004-002320-91
Protocol number AP-AS-21-DE; S020801
Sponsor Fresenius Biotech, GmbH, Graefelfing, Germany
Indications Hemato-oncology
Diagnosis acute lymphoblastic/myeloid leukemia, myelodysplastic syndrome
Population in clinical trial Adults (18-65 years)
Male
Female
Patients
Year of receiving the request to Institute (SÚKL) 2004
Date of approval by Institute (SÚKL) 23.07.2004
Date of approval by EC
Date of initiation CT in ČR
Date of ending CT in ČR
Notice
Sites Hemato-onkologické oddělení, Fakultní nemocnice Plzeň, alej Svobody 80, 304 60 Plzeň
II. interní klinika, Fakultní nemocnice Brno-Bohunice, Jihlavská 20, 639 00 Brno-Bohunice

‹‹ Back to list